On Tuesday, October 13, Johnson & Johnson JNJ will release its latest earnings report. Here is Benzinga's outlook for the company.
Earnings and Revenue
Based on management's projections, Johnson & Johnson analysts model for earnings of $1.96 per share on sales of $20.13 billion. In the same quarter last year, Johnson & Johnson reported EPS of $2.12 on revenue of $20.73 billion. If the company were to match the consensus estimate when it reports Tuesday, earnings would be down 7.55%. Revenue would be down 2.89% from the same quarter last year. Here is how the company's reported EPS has stacked up against analyst estimates in the past:
| Quarter | Q2 2020 | Q1 2020 | Q4 2020 | Q3 2019 |
|---|---|---|---|---|
| EPS Estimate | 1.48 | 1.99 | 1.87 | 2 |
| EPS Actual | 1.67 | 2.30 | 1.88 | 2.12 |
| Revenue Estimate | 17.50 B | 19.44 B | 20.78 B | 20.09 B |
| Revenue Actual | 18.34 B | 20.69 B | 20.75 B | 20.73 B |
Stock Performance
Shares of Johnson & Johnson were trading at $150.93 as of October 09. Over the last 52-week period, shares are up 14.44%. Given that these returns are generally positive, long-term shareholders are probably satisfied going into this earnings release.
Do not be surprised to see the stock move on comments made during its conference call. Johnson & Johnson is scheduled to hold the call at 08:30:00 ET and can be accessed here: https://edge.media-server.com/mmc/p/k7ozm2yc
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Date | ticker | name | Actual EPS | EPS Surprise | Actual Rev | Rev Surprise |
|---|
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
